Post by Harbour BioMed

Excited to announce that Dr. Luisa Salter-Cid has joined Harbour BioMed as a Scientific Advisor! 🎉 🎉 Luisa brings over 20 years of outstanding leadership across the biotech and pharmaceutical landscape, with senior executive roles at Flagship Pioneering, Bristol Myers Squibb, and Gossamer Bio. Her deep expertise in Immunology and Immuno-Oncology and her proven ability to translate scientific insights into clinical-stage assets will be invaluable as we work to expand our pipeline of differentiated antibody therapeutics. A few highlights from her remarkable career: 🔬 Former VP & Head of Immunology, Small Molecule Immuno-Oncology, and Genomics Discovery at BMS, where she led teams that advanced over 20 compounds into clinical development. 💡 Former CSO of Pioneering Medicines at Flagship Pioneering and CSO at Gossamer Bio. 📚 Author of more than 90 publications and patents. 🌟 Currently a Venture Partner at Osage University Partners. We believe Luisa’s strategic insights into next-generation drug development will significantly bolster our efforts to address unmet medical needs globally, and we look forward to working with her to advance our cutting-edge science to bring life-saving medicines to patients. 🔗 Read the full announcement here: https://lnkd.in/djWwPHkZ #Immunology #ImmunoOncology #AntibodyTherapeutics #Leadership #ScientificAdvisoryBoard #DrugDiscovery